Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Osborne: Ganglion cell death in glaucoma: what do we really know?. (0.13 sec) 

Ganglion cell death in glaucoma: what do we really know?

- nih.gov [PDF]  - Free from Publisher
NN Osborne, JPM Wood, G Chidlow, JH Bae, … - British Journal of Ophthalmology, 1999 - bjo.bmj.com
Glaucomatous optic neuropathy is a chronic process which progresses over many
years. Data derived from clinical observations and from animal experiments
suggest that the axons of the optic nerve and the retinal ganglion cell ...
Cited by 65 - Related articles - BL Direct - All 8 versions

Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the …


NN Osborne, L DeSantis, JH Bae, M Ugarte, … - Experimental eye research, 1999 - Elsevier
The present results show that topically applied Betoptic®(0.5% betaxolol) to
the rabbit or rat eye reaches the retina and can counteract the detrimental
effects caused by ischaemia/reperfusion or N -methyl- -aspartate ...
Cited by 89 - Related articles - BL Direct - All 6 versions

Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction


CE CROSSON, JA WILLIS, DE POTTER - Journal of Ocular Pharmacology and Therapeutics, 1990 - liebertonline.com
Page 1. JOURNAL OF OCULAR PHARMACOLOGY Volume 6, Number 4. 1990 Mary Ann Liebert,
Inc., Publishers Effect of the Calcium Antagonist, Nifedipine, ...
Cited by 42 - Related articles - All 2 versions

The potential of neuroprotection in glaucoma treatment


NN Osborne, G Chidlow, MS Nash, JPM … - Current Opinion in Ophthalmology, 1999 - journals.lww.com
Visual field loss in glaucoma is due to death of retinal ganglion cells.
Reducing or slowing down the loss of ganglion cells in glaucoma, a concept known
as neuroprotection, would appear to be the only way forward. This does not ...
Cited by 43 - Related articles - BL Direct - All 2 versions

Neuroprotection: is it already applicable to glaucoma therapy?


R Ritch - Current opinion in ophthalmology, 2000 - journals.lww.com
Many categories of both natural and synthetic compounds have been reported to
have neuroprotective activity. These include not only antioxidants,
N-methyl-D-aspartate receptor antagonists, inhibitors of glutamate release, ...
Cited by 30 - Related articles - BL Direct - All 4 versions

Betaxolol, a β1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels


J Melena, JPM Wood, N N. Osborne - European journal of pharmacology, 1999 - Elsevier
The effect of betaxolol on the specific binding of [ 3 H]diltiazem and [ 3
H]nitrendipine to rat cortical membranes was examined. Betaxolol inhibited
specific [ 3 H]diltiazem and [ 3 H]nitrendipine binding with IC 50 values ...
Cited by 38 - Related articles - All 5 versions

Expectations in the treatment of retinal diseases: neuroprotection


NN Osborne, G Chidlow, JPM Wood, KG … - Current Eye Research, 2001 - informahealthcare.com
Loss of vision leading to blindness is commonly due to pho- toreceptor or
ganglion cell malfunction. No evidence exists to suggest that a lesion
associated with other retinal cell- types (Müller cells, horizontal cells, ...
Cited by 23 - Related articles - BL Direct - All 5 versions

A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve …

- nih.gov [PDF]  - Free from Publisher
NN OSBORNE, J MELENA, G CHIDLOW, … - British Journal of Ophthalmology, 2001 - bjo.bmj.com
Raised IOP is not the sole factor responsible for glaucomatous retinal damage
but an important one of a number that have been implicated (Fig 1).12-17 Only
10% of patients with increased IOP (⩾22 mm Hg) have glaucoma and between ...
Cited by 58 - Related articles - BL Direct - All 14 versions

Neuroprotection in relation to retinal ischemia and relevance to glaucoma


NN Osborne, M Ugarte, M Chao, G Chidlow, … - Survey of ophthalmology, 1999 - Elsevier
Management of glaucoma is directed at the control of intraocular pressure (IOP),
yet it is recognized now that increased IOP is just an important risk factor in
glaucoma. Therapy that prevents the death of ganglion cells is the main ...
Cited by 211 - Related articles - BL Direct - All 10 versions

An investigation into the potential mechanisms underlying the neuroprotective effect of …


HM Chao, G Chidlow, J Melena, JPM Wood, … - Brain research, 2000 - Elsevier
There are a variety of possible ways in which neuroprotection can be induced
through activation of α 2 -adrenoceptors. Hypoxia/ischaemia is considered to
result in the excessive release of neurotransmitters from affected cells, ...
Cited by 29 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google